- Home
- Publications
- Publication Search
- Publication Details
Title
Recent progress in TGF-β inhibitors for cancer therapy
Authors
Keywords
Small-molecule inhibitor, Cancer therapy, TGF-β inhibitor, Endocytosis, Lipid raft
Journal
BIOMEDICINE & PHARMACOTHERAPY
Volume 134, Issue -, Pages 111046
Publisher
Elsevier BV
Online
2020-12-17
DOI
10.1016/j.biopha.2020.111046
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Increased expression of the transforming growth factor β–inducible gene HIC-5 in systemic sclerosis skin and fibroblasts: a novel antifibrotic therapeutic target
- (2020) Sonsoles Piera-Velazquez et al. RHEUMATOLOGY
- Understanding Fibrosis in Systemic Sclerosis: Novel and Emerging Treatment Approaches
- (2020) Hanlin Yin et al. Current Rheumatology Reports
- Transforming Growth Factor-β Signaling in Immunity and Cancer
- (2019) Eduard Batlle et al. IMMUNITY
- Transforming growth factor β signaling pathway: A promising therapeutic target for cancer
- (2019) Yuhong Chen et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Roles of Myosin-Mediated Membrane Trafficking in TGF-β Signaling
- (2019) Chih-Ling Chung et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Matrix stiffness modulates ILK-mediated YAP activation to control the drug resistance of breast cancer cells
- (2019) Xiang Qin et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Cancer-associated fibroblast regulate proliferation and migration of prostate cancer cells through TGF-β signaling pathway
- (2019) Dai-Yu Sun et al. LIFE SCIENCES
- Sorafenib suppresses TGF-β responses by inducing caveolae/lipid raft-mediated internalization/degradation of cell-surface type II TGF-β receptors: Implications in development of effective adjunctive therapy for hepatocellular carcinoma
- (2018) Chih-Ling Chung et al. BIOCHEMICAL PHARMACOLOGY
- Polyprenylated polycyclic acylphloroglucinol: Angiogenesis inhibitor from Garcinia multiflora
- (2018) Lin-Yang Cheng et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Pentachloropseudilin Inhibits Transforming Growth Factor-β (TGF-β) Activity by Accelerating Cell-Surface Type II TGF-β Receptor Turnover in Target Cells
- (2018) Chih-Ling Chung et al. CHEMBIOCHEM
- Pentabromopseudilin: a myosin V inhibitor suppresses TGF-β activity by recruiting the type II TGF-β receptor to lysosomal degradation
- (2018) Wang Shih-Wei et al. JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY
- Phosphorylation status at Smad3 linker region modulates TGF-β-induced EMT and cancer progression
- (2018) Akira Ooshima et al. CANCER SCIENCE
- First-in-human phase I study of ISTH0036, an antisense oligonucleotide selectively targeting transforming growth factor beta 2 (TGF-β2), in subjects with open-angle glaucoma undergoing glaucoma filtration surgery
- (2017) Norbert Pfeiffer et al. PLoS One
- Pentabromophenol suppresses TGF-β signaling by accelerating degradation of type II TGF-β receptors via caveolae-mediated endocytosis
- (2017) Chun-Lin Chen et al. Scientific Reports
- Phase II study of Vigil® DNA engineered immunotherapy as maintenance in advanced stage ovarian cancer
- (2016) Jonathan Oh et al. GYNECOLOGIC ONCOLOGY
- A Small Dibromotyrosine Derivative Purified FromPseudoceratinaSp. Suppresses TGF-β Responsiveness by Inhibiting TGF-β Type I Receptor Serine/Threonine Kinase Activity
- (2016) Chun-Lin Chen et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- DMSO Enhances TGF-β Activity by Recruiting the Type II TGF-β Receptor From Intracellular Vesicles to the Plasma Membrane
- (2016) Shuan Shian Huang et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- 7-Dehydrocholesterol (7-DHC), But Not Cholesterol, Causes Suppression of Canonical TGF-β Signaling and Is Likely Involved in the Development of Atherosclerotic Cardiovascular Disease (ASCVD)
- (2016) Shuan Shian Huang et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Cholest-4-en-3-one attenuates TGF-β responsiveness by inducing TGF-β receptors degradation in Mv1Lu cells and colorectal adenocarcinoma cells
- (2016) Chun-Lin Chen et al. JOURNAL OF RECEPTORS AND SIGNAL TRANSDUCTION
- Three-year Follow up of GMCSF/bi-shRNA furin DNA-transfected Autologous Tumor Immunotherapy (Vigil) in Metastatic Advanced Ewing's Sarcoma
- (2016) Maurizio Ghisoli et al. MOLECULAR THERAPY
- Transcriptional Control by the SMADs
- (2016) Caroline S. Hill Cold Spring Harbor Perspectives in Biology
- Reversible Human TGF-β Signal Shifting between Tumor Suppression and Fibro-Carcinogenesis: Implications of Smad Phospho-Isoforms for Hepatic Epithelial-Mesenchymal Transitions
- (2016) Katsunori Yoshida et al. Journal of Clinical Medicine
- Effect of P144® (Anti-TGF-β) in an “In Vivo” Human Hypertrophic Scar Model in Nude Mice
- (2016) Shan Shan Qiu et al. PLoS One
- Resveratrol suppresses epithelial-to-mesenchymal transition in colorectal cancer through TGF-β1/Smads signaling pathway mediated Snail/E-cadherin expression
- (2015) Qing Ji et al. BMC CANCER
- Cutaneous keratoacanthomas/squamous cell carcinomas associated with neutralization of transforming growth factor β by the monoclonal antibody fresolimumab (GC1008)
- (2015) Mario E. Lacouture et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- A phase III study of belagenpumatucel-L, an allogeneic tumour cell vaccine, as maintenance therapy for non-small cell lung cancer
- (2015) G. Giaccone et al. EUROPEAN JOURNAL OF CANCER
- Ethanol Enhances TGF-β Activity by Recruiting TGF-β Receptors From Intracellular Vesicles/Lipid Rafts/Caveolae to Non-Lipid Raft Microdomains
- (2015) Shuan Shian Huang et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Pilot Trial of FANG Immunotherapy in Ewing's Sarcoma
- (2015) Maurizio Ghisoli et al. MOLECULAR THERAPY
- Reciprocal regulation of TGF-β and reactive oxygen species: A perverse cycle for fibrosis
- (2015) Rui-Ming Liu et al. Redox Biology
- TGFβSignaling in Tumor Initiation, Epithelial-to-Mesenchymal Transition, and Metastasis
- (2015) Panagiotis Papageorgis Journal of Oncology
- Euphol from Euphorbia tirucalli Negatively Modulates TGF-β Responsiveness via TGF-β Receptor Segregation inside Membrane Rafts
- (2015) Chun-Lin Chen et al. PLoS One
- Trimodal Glioblastoma Treatment Consisting of Concurrent Radiotherapy, Temozolomide, and the Novel TGF-β Receptor I Kinase Inhibitor LY2109761
- (2015) Mengxian Zhang et al. NEOPLASIA
- A phase I dose-escalation study to a predefined dose of a transforming growth factor-β1 monoclonal antibody (TβM1) in patients with metastatic cancer
- (2014) ALLEN COHN et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- EW-7197, a Novel ALK-5 Kinase Inhibitor, Potently Inhibits Breast to Lung Metastasis
- (2014) J. Y. Son et al. MOLECULAR CANCER THERAPEUTICS
- Phase I Study of GC1008 (Fresolimumab): A Human Anti-Transforming Growth Factor-Beta (TGFβ) Monoclonal Antibody in Patients with Advanced Malignant Melanoma or Renal Cell Carcinoma
- (2014) John C. Morris et al. PLoS One
- Transforming Growth Factor-Beta and Matrix Metalloproteinases: Functional Interactions in Tumor Stroma-Infiltrating Myeloid Cells
- (2014) Jelena Krstic et al. TheScientificWorldJOURNAL
- Combined Treatment with Erlotinib and a Transforming Growth Factor-β Type I Receptor Inhibitor Effectively Suppresses the Enhanced Motility of Erlotinib-Resistant Non–Small-Cell Lung Cancer Cells
- (2013) Masakuni Serizawa et al. Journal of Thoracic Oncology
- Differential Inhibition of the TGF-β Signaling Pathway in HCC Cells Using the Small Molecule Inhibitor LY2157299 and the D10 Monoclonal Antibody against TGF-β Receptor Type II
- (2013) Francesco Dituri et al. PLoS One
- Comparative Analysis of TGF-β/Smad Signaling Dependent Cytostasis in Human Hepatocellular Carcinoma Cell Lines
- (2013) Johanna Dzieran et al. PLoS One
- Complexities of TGF-β Targeted Cancer Therapy
- (2012) Erin C. Connolly et al. International Journal of Biological Sciences
- Dynamics of targeted cancer therapy
- (2012) Ivana Bozic et al. TRENDS IN MOLECULAR MEDICINE
- Outgrowth of Drug-Resistant Carcinomas Expressing Markers of Tumor Aggression after Long-term T RI/II Kinase Inhibition with LY2109761
- (2011) E. C. Connolly et al. CANCER RESEARCH
- Transforming growth factor-beta 2 gene silencing with trabedersen (AP 12009) in pancreatic cancer
- (2011) Karl-Hermann Schlingensiepen et al. CANCER SCIENCE
- TGF-β in progression of liver disease
- (2011) Steven Dooley et al. CELL AND TISSUE RESEARCH
- Phase I Trial of TGF- 2 Antisense GM-CSF Gene-Modified Autologous Tumor Cell (TAG) Vaccine
- (2011) J. Olivares et al. CLINICAL CANCER RESEARCH
- The Antisense Oligonucleotide Trabedersen (AP 12009) for the Targeted Inhibition of TGF-β2
- (2011) Frank Jaschinski et al. CURRENT PHARMACEUTICAL BIOTECHNOLOGY
- A phase 1, single-dose study of fresolimumab, an anti-TGF-β antibody, in treatment-resistant primary focal segmental glomerulosclerosis
- (2011) Howard Trachtman et al. KIDNEY INTERNATIONAL
- Phase I Trial of “bi-shRNAifurin/GMCSF DNA/Autologous Tumor Cell” Vaccine (FANG) in Advanced Cancer
- (2011) Neil Senzer et al. MOLECULAR THERAPY
- Understanding fibrosis in systemic sclerosis: shifting paradigms, emerging opportunities
- (2011) Swati Bhattacharyya et al. Nature Reviews Rheumatology
- Roles of matrix metalloproteinases in cancer progression and their pharmacological targeting
- (2010) Chrisostomi Gialeli et al. FEBS Journal
- Connection between inflammation and carcinogenesis in gastrointestinal tract: Focus on TGF-β signaling
- (2010) Suntaek Hong WORLD JOURNAL OF GASTROENTEROLOGY
- Matrix Crosslinking Forces Tumor Progression by Enhancing Integrin Signaling
- (2009) Kandice R. Levental et al. CELL
- Oxidative stress and glutathione in TGF-β-mediated fibrogenesis
- (2009) R.-M. Liu et al. FREE RADICAL BIOLOGY AND MEDICINE
- Keratoacanthomas and Squamous Cell Carcinomas in Patients Receiving Sorafenib
- (2009) Jean Philippe Arnault et al. JOURNAL OF CLINICAL ONCOLOGY
- An Anti-Transforming Growth Factor Antibody Suppresses Metastasis via Cooperative Effects on Multiple Cell Compartments
- (2008) J.-S. Nam et al. CANCER RESEARCH
- Endocytic regulation of TGF-β signaling
- (2008) Ye-Guang Chen CELL RESEARCH
- Transforming growth factor-β gene expression signature in mouse hepatocytes predicts clinical outcome in human cancer
- (2008) Cédric Coulouarn et al. HEPATOLOGY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started